Application

19604590 · ANTIBODIES CAPABLE OF SPECIFICALLY BINDING TL1A AND USE THEREOF

Filed 2026-07-08 · Pending The official file ↗ · Art unit · FUTUREGEN BIOPHARMACEUTICAL (BEIJING) CO., LTD. · MCCARTER & ENGLISH, LLP BOSTON

Office actions

first was

RCEs

no appeal

To first action

n/a

to disposition n/a

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.